Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (71-80 of 212) with videos related to

Pageof 22
Sort By:
Pediatric Blood & Cancer|September 26, 2018
Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell linesMonish R Makena, Hwang Eui Cho, Thinh H Nguyen, et al.
Molecular Cancer Therapeutics|September 6, 2019
Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical ModelsThinh H Nguyen, Balakrishna Koneru, Sung-Jen Wei, et al.
Anti-Cancer Drugs|October 20, 2020
Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignanciesMonish Ram Makena, Thinh H Nguyen, Balakrishna Koneru, et al.
Pediatric Blood & Cancer|February 9, 2012
Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcomaMalcolm A Smith, Min H Kang, C Patrick Reynolds, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 12, 2012
Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicityAnastasia Shibina, Diana Seidel, Srinivas S Somanchi, et al.
Anticancer Research|April 19, 2011
Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomasShivaani Kummar, Martin E Gutierrez, Barry J Maurer, et al.
Blood|May 31, 2007
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivoMin H Kang, Yun Hee Kang, Barbara Szymanska, et al.
British Journal of Pharmacology|March 12, 2011
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposureJason P Cooper, Kyunghwa Hwang, Hardeep Singh, et al.
Journal of Neuro-Oncology|November 29, 2011
Novel cell lines established from pediatric brain tumorsJingying Xu, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez, et al.
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Pageof 22

Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
Pediatric Blood & Cancer|September 26, 2018
Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell linesMonish R Makena, Hwang Eui Cho, Thinh H Nguyen, et al.
Molecular Cancer Therapeutics|September 6, 2019
Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical ModelsThinh H Nguyen, Balakrishna Koneru, Sung-Jen Wei, et al.
Anti-Cancer Drugs|October 20, 2020
Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignanciesMonish Ram Makena, Thinh H Nguyen, Balakrishna Koneru, et al.
Pediatric Blood & Cancer|February 9, 2012
Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcomaMalcolm A Smith, Min H Kang, C Patrick Reynolds, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 12, 2012
Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicityAnastasia Shibina, Diana Seidel, Srinivas S Somanchi, et al.
Anticancer Research|April 19, 2011
Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomasShivaani Kummar, Martin E Gutierrez, Barry J Maurer, et al.
Blood|May 31, 2007
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivoMin H Kang, Yun Hee Kang, Barbara Szymanska, et al.
British Journal of Pharmacology|March 12, 2011
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposureJason P Cooper, Kyunghwa Hwang, Hardeep Singh, et al.
Journal of Neuro-Oncology|November 29, 2011
Novel cell lines established from pediatric brain tumorsJingying Xu, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez, et al.
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Pageof 22